Global Vitiligo Atlas
.png)
Welcome to GLOVA: The Global Vitiligo Atlas
Vitiligo is a complex, autoimmune skin condition that causes loss of skin pigmentation due to melanocyte destruction. While not life-threatening, its visible nature often affects psychological wellbeing of those with vitiligo, many who are severely affected by depression, anxiety, a feeling of stigmatisation and suicidal ideations. The Global Vitiligo Atlas (GLOVA) is a ground-breaking initiative to create and maintain an atlas, through a comprehensive global data repository, where all data is available in one place, across all countries.
GLOVA aims to advance our understanding of:
​
-
Epidemiology of vitiligo (such as information on how many people have vitiligo). Epidemiological studies also help investigating the natural history of vitiligo and identify environmental factors influencing disease onset or flare and its comorbidities.
-
Availability of care and effectiveness of various treatment modalities in real world
-
Burden of vitiligo on its bearers including defining what is severity and flare up in vitiligo as well as quantifying stigma and difficulties in job and job access.​
By integrating clinical, genetic and demographic insights, GLOVA serves as a central resource for researchers, clinicians and policymakers, driving innovations in precision medicine, highlighting health inequities, and fostering international collaboration. Join us in shaping the future of vitiligo research and care, empowering better outcomes for individuals and communities worldwide.
Introducing the Global Vitiligo Atlas (GLOVA):
Established in 2022, GLOVA is a comprehensive initiative dedicated to advancing our understanding of vitiligo and its societal impact.
Led by Professors Khaled Ezzedine (Université Paris-Est Créteil Val de Marne-Université Paris, France) and Viktoria Eleftheriadou (University of Birmingham, UK), GLOVA is a collaborative project between three prominent global dermatology organisations: the ILDS, the Vitiligo International Society (VIS) and the Vitiligo Patient Organisation (VIPOC).​
GLOVA is comprised of three separate projects, which aim to publish an epidemiology atlas, create an international registry to study pharmacovigilance of vitiligo drugs (VIRTUAL Global) and reach a global consensus on disease severity and flare ups (INTERCEPT).
Epidemiology Atlas To Prioritise Research
International Pharmacovigilance Registry (VIRTUAL Global)